MOLDOVA

Image

MOLDOVA

242,364

Total Cases

5,438

Total Deaths

225,036

Total Recovered

11,890

Total Active Cases

+29

New Deaths

+544

New Cases


via schengenvisainfo04/12/2021

Lithuania Imposes More Stringent Rules for Arrivals From Croatia & Turkey - SchengenVisaInfo.com - SchengenVisaInfo.com

The Government of Lithuania has announced more stringent measures for all persons arriving from Croatia and Turkey due to the high risk of COVID-19 currently prevailing in these two countries. All persons entering from Croatia or Turkey are required to submit a negative Coronavirus test result and stay self-isolated for ten days. On the other […]

via urdupoint04/09/2021

Moldova's Pro-Presidential Party Challenges Legality of COVID-19 State of Emergency - UrduPoint News

Moldovas pro-presidential Party of Action and Solidarity (PAS) has appealed to the countrys Constitutional Court, asking that a recently-imposed COVID-19 state of emergency be recognized as unconstitutional, (PAS) lawmaker Sergey Litvinenko said on Friday.On March 30, the Moldovan parliament appro ..

via urdupoint04/05/2021

Moldova's Dodon Says Reprieve Before New Wave of COVID Should Be Used to Boost Healthcare - UrduPoint News

Moldova should use the recent lull in new cases of COVID-19 wave to strengthen its healthcare system, Igor Dodon, a former Moldovan president and the current leader of the Party of Socialists, said on Monday.In the near future, we have to use this respite of several weeks before the next wave, whic ..

via arabnews04/02/2021

Super-spreader fears in India as millions gather for month-long festival - Arab News

NEW DELHI: The Kumbh Mela festival has stoked coronavirus super-spreader fears in India as millions of pilgrims are expected to flock to the Ganges River every day during the month-long celebrations. Kumbh Mela, which started on Thursday, is the biggest festival of Hinduism, with the faithful coming from across the country to the holy waters for a ritual dip. This year,


via arabnews04/01/2021

UK rejects US call to repatriate Daesh members - Arab News

LONDON: The UK has rejected US calls to bring home British militants and their families from detention in Syria. John Godfrey, US special envoy for the anti-Daesh coalition, warned that the battlefield victory over the terrorist group will be squandered if Western countries refuse to take responsibility for their citizens held in camps in Syria.

via arabnews03/30/2021

Three women medical staff shot dead in Afghanistan - Arab News

KABUL: Three Afghan women working on a UN-funded anti-polio vaccination drive were killed in two separate attacks by unidentified gunmen on Tuesday in Afghanistan’s eastern city of Jalalabad, officials told Arab News. “We can confirm that three women vaccinators were killed by armed men in two different areas of the city,” Attuallah Khogyani, spokesman for Nangarhar’s

via emerging-europe03/30/2021

Romania, where Covid-19 restrictions are modest, but fools protest anyway - Emerging Europe

There is no Covid-19 lockdown in Romania. The terraces of cafes and restaurants are full, shops are open, parks teem with parents and children. And yet as alarming numbers of people become infected with coronavirus and die, others are protesting - some violently - against some very loose restrictions.

via zee504/12/2021

JIBS organizes International Scientific Conference on “Mental Health, Well-Being and Loneliness during C - ZEE5 News

New Delhi [India], April 12 (ANI/OP Jindal University): Jindal Institute of Behavioural Sciences (JIBS), OP Jindal Global University in collaboration with Free International University of Moldova organized the International Scientific Conference on "Mental Health, Well-Being and Loneliness during COVID-19" from April 09-10.

via who.int04/08/2021

COVAX reaches over 100 economies, 42 days after first international delivery - World Health Organization

The COVAX Facility has now delivered life-saving vaccines to over 100 economies since making its first international delivery to Ghana on 24 February 2021So far, more than 38 million doses of vaccines from manufacturers AstraZeneca, Pfizer-BioNTech and Serum Institute of India (SII) have now been delivered, including 61 economies eligible for vaccines through the Gavi COVAX Advance Market Commitment COVAX aims to supply vaccines to all participating economies that have requested vaccines, in the first half of 2021, despite some delays in planned deliveries for March and April.More than one hundred economies have received life-saving COVID-19 vaccines from COVAX, the global mechanism for equitable access to COVID-19 vaccines. The milestone comes 42 days after the first COVAX doses were shipped and delivered internationally, to Ghana on 24 February 2021.COVAX has now delivered more than 38 million doses across six continents, supplied by three manufacturers, AstraZeneca, Pfizer-BioNTech and the Serum Institute of India (SII). Of the over 100 economies reached, 61 are among the 92 lower-income economies receiving vaccines funded through the Gavi COVAX Advance Market Commitment (AMC).Despite reduced supply availability in March and April – the result of vaccine manufacturers scaling and optimising their production processes in the early phase of the rollout, as well as increased demand for COVID-19 vaccines in India – COVAX expects to deliver doses to all participating economies that have requested vaccines in the first half of the year.“In under four months since the very first mass vaccination outside a clinical setting anywhere in the world, it is tremendously gratifying that the roll-out of COVAX doses has already reached one hundred countries,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. “COVAX may be on track to deliver to all participating economies in the first half of the year yet we still face a daunting challenge as we seek to end the acute stage of the pandemic: we will only be safe when everybody is safe and our efforts to rapidly accelerate the volume of doses depend on the continued support of governments and vaccine manufacturers. As we continue with the largest and most rapid global vaccine rollout in history, this is no time for complacency.”“COVAX has given the world the best way to ensure the fastest, most equitable rollout of safe and effective vaccines to all at-risk people in every country on the planet,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “If we are going to realize this great opportunity, countries, producers and the international system must come together to prioritize vaccine supply through COVAX. Our collective future, literally, depends on it.”"This is a significant milestone in the fight against COVID-19. Faced with the rapid spread of COVID-19 variants, global access to vaccines is fundamentally important to reduce the prevalence of the disease, slow down viral mutation, and hasten the end of the pandemic,” said Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI). “The extraordinary scientific achievements of the last year must now be matched by an unprecedented effort to protect the most vulnerable, so the global community must remain firmly focused on reducing the equity gap in COVID-19 vaccine distribution." “In just a month and a half, the ambition of granting countries access to COVID vaccines is becoming a reality, thanks to the outstanding work of our partners in the COVAX Facility,” said Henrietta Fore, UNICEF Executive Director. “However, this is no time to celebrate; it is time to accelerate. With variants emerging all over the world, we need to speed up global rollout. To do this, we need governments, along with other partners, to take necessary steps to increase supply, including by simplifying barriers to intellectual property rights, eliminating direct and indirect measures that restrict exports of COVID-19 vaccines, and donating excess vaccine doses as quickly as possible.”According to its latest supply forecast, COVAX expects to deliver at least 2 billion doses of vaccines in 2021. In order to reach this goal, the COVAX Facility will continue to diversify its portfolio further, and will announce new agreements with vaccine manufacturers in due course. Furthermore, in March it was announced that the United States government will host the launch event for the 2021 Gavi COVAX AMC Invest Opportunity to catalyze further commitment and support for accelerated access to vaccines for AMC-supported economies. An additional US$ 2 billion is required in 2021 to finance and secure up to a total of 1.8 billion donor-funded doses of vaccines. COVAX is also working to secure additional sourcing of vaccines in the form of dose-sharing from higher income countries.Quotes from donors and partnersPresident of the European Commission Ursula von der Leyen said: “As we continue our common race to speed up safe and effective vaccination everywhere, I want to commend COVAX for having delivered first vaccines to 100 countries in every corner of the world, including some of the most vulnerable warn torn countries like Afghanistan and Yemen. This is a real milestone. Team Europe has strongly invested in COVAX and I urge all partners to support COVAX to make sure no one is left behind”.  Senator the Hon Marise Payne, Minister for Foreign Affairs and Minister for Women, Australia said: “Australia welcomes the progress made by COVAX in COVID-19 vaccine distribution across the world. One hundred countries now have access to life-saving COVID-19 vaccines through COVAX. We are proud to work with global partners to achieve equitable global access to safe and effective vaccines.”Karina Gould, Minister of International Development, Canada and co-chair, COVAX AMC Engagement Group said: “Despite the many challenges it faced, the COVAX Facility has continued to deliver. In just a matter of weeks, it’s been supplying vaccines to 100 countries. This is a milestone we can all be proud of. Now, more than ever, we must continue to work together and support multilateral mechanisms like the COVAX Facility and the ACT-Accelerator.”  Jean-Yves le Drian, Minister of Europe and Foreign Affairs, France said: “One hundred countries have now received safe, WHO-approved vaccines against COVID-19 through the COVAX Facility. France welcomes this crucial step forward, which demonstrates that multilateralism in global health, as well as the spirit of solidarity and responsibility on which it is based, constitutes the most effective response to this pandemic. But the fight against the virus is far from over: we must continue to support COVAX and accelerate equitable access to vaccines in fragile countries, in particular through sharing of vaccine doses. This is what France wants to do, together with its EU and G7 partners.”Dr Gerd Müller, Federal Minister for Economic Cooperation and Development, Germany said: “We either beat the pandemic worldwide or we will not beat it at all. The only way out of the crisis is a global immunization campaign. In order to now be able to vaccinate people quickly, we are using the tried and tested structures of the global vaccine alliance Gavi. Thanks to the vaccination platform COVAX, the structures are in place to provide vaccines for at least 20 per cent of people in developing countries and emerging economies over the course of this year.”Heiko Maas, Minister of Foreign Affairs, Germany said: “The fact that St.Lucia yesterday became the 100th country to be supplied with vaccines via the COVAX platform supported by Germany and the EU, is a milestone on the way out of the pandemic. This progress gives us hope, for we too will only be safe when everyone around the world is safe. Access to vaccines, medicines and tests must not become a geopolitical pawn. Rather, they must be available to all countries in a fair and transparent manner. That’s why we’re committed to COVAX, to a multilateral approach.”Colm Brophy TD, Minister of State for Overseas Development and the Diaspora, Ireland said: “Through our funding to COVAX, Ireland is supporting developing countries, who most need vaccines and can least afford them, secure their share of global supply.”Dag-Inge Ulstein, Minister of International Development, Norway, and Co-chair of the ACT-Accelerator Facilitation Council said: “In less than a year, the world has come together to develop and secure equitable global access to COVID-19 vaccines. That is a huge victory. But the risk of vaccine nationalism is still looming large. Countries and manufactures must prioritize global solutions. It is also crucial that all manufacturers continue to make their vaccines available and affordable to COVAX, so that the global rollout can continue. Countries that have more vaccines than they need should share vaccines through COVAX. I also expect all relevant stakeholders to take action to ensure that the world can produce enough vaccines, at a price that even the poorest countries can afford.”H.E. Dr Tawfig AlRabiah, Minister of Health in Saudi Arabia said: “‘People’s health first’ has been the guiding principle, driving all efforts in the fight against the pandemic - both nationally and globally - to ensure that “No one is left behind”. We in the kingdom are proud contributors to GAVI and the COVAX facility, which has now shipped over 37 million vaccines. This show of solidarity is the cure to fighting COVID-19, and our collective resilience will enable us to overcome any future pandemic we may face.”  Foreign, Commonwealth and Development Office Minister Wendy Morton, United Kingdom said: “From Nigeria to Nepal, COVAX has now delivered life-saving vaccine doses to 100 countries and territories which is a huge achievement and another step towards making us all safe. The UK has played a leading role in achieving equitable access to vaccines by providing £548 million for COVAX early on, which will help to deliver more than one billion doses around the world, as well as lobbying international partners to increase their funding.”United States Secretary of State Antony J. Blinken said: “The United States welcomes the news that COVAX has delivered safe and effective COVID-19 vaccines to 100 countries.  The United States signaled our strong support for COVAX through an initial $2 billion contribution to Gavi.  Through unprecedented partnerships among donors, manufacturers, and participating countries, COVAX has achieved extraordinary milestones in equitably distributing doses to the global community in record time.” Werner Hoyer, President of the European Investment Bank said: “As part of Team Europe the European Investment Bank is pleased to provide EUR 400 million for COVAX, representing the EIB’s largest ever support for global public health. COVAX has already provided vaccines to vulnerable groups and front line workers and brought hope to millions more. COVAX demonstrates the benefit of global cooperation to tackle the shared challenge of COVID. Congratulations to the COVAX team and global partners in 100 countries around the world. Together we are ensuring equitable access to vaccines and together we are directing our efforts towards a global recovery.”Pascal Soriot, AstraZeneca CEO, said: “Today marks a significant milestone in the global fight against the pandemic as 100 countries have received vaccine through COVAX. I am proud that the supply of our vaccine accounts for the vast majority of doses being delivered through COVAX in the first half of this year. Over 37 million doses of our vaccine have been delivered to date which are protecting the most vulnerable populations around the world.  Together with our COVAX partners, we continue to work 24/7 to deliver on our unwavering commitment to broad, equitable and affordable access.”Pfizer Chairman and CEO Albert Bourla said: “Congratulations to everyone who has worked tirelessly to reach this impressive milestone. At Pfizer we are driven every day by the belief that science will win. Through collaboration and commitment, COVAX has brought forth a global solution that helps to bring breakthrough science to everyone, everywhere. We are proud to work together with the facility and all of its partners and remain firmly committed to working toward the shared vision of equitable access for all to end this pandemic.” Sai D. Prasad, President, Developing Countries Vaccines Manufacturing Network (DCVMN) said: “COVAX has made history by ensuring equitable access for COVID-19 vaccines to all countries irrespective of their economic status. The 100th delivery marks a great milestone for COVAX, leading to enhanced deliveries during 2021. We commend the efforts by all partners in COVAX for this achievement. Developed and developing country manufacturers have played a crucial role in product development and large scale manufacturing. In order to meet the requirements of all countries, more partnerships between innovators and manufacturers are required. COVAX’s leadership in COVID-19 vaccines will ensure that we leave no one behind.”Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) & founding partner of ACT-A said: “The timeline is truly impressive; one that is difficult to square with warnings of “catastrophic moral failure”. It’s an innovation success story with the first WHO vaccine approval on 31 December 2021, less than a year after the virus was first shared. It’s a manufacturing success story with the scaling up from zero to one billion doses being produced by April 2021. It is a logistics and country preparedness success story, with 100 countries receiving the vaccines. And last but by no means least, it’s a collaboration and solidarity success story thanks to the commitment from donors and the tireless efforts of the partners of COVAX including the developing and the developed world manufacturers. The COVAX public private partnership and political leadership to equitably share surplus vaccines are the best guarantees we have that people who need the vaccine will get it whenever they live, fast enough to outpace the virus’ mutations.”Notes to editorsThe list of 102 Facility participants (as of 14h CET, 8 April) that have received a combined total of 38,392,540 doses of COVAX-delivered vaccines so far is as follows (in alphabetical order):Afghanistan, Albania, Algeria, Andorra, Angola, Argentina, Armenia, Azerbaijan, Bahamas, Bahrain, Barbados, Belize, Benin, Bermuda, Bolivia (Plurinational State of), Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Cabo Verde, Cambodia, Canada, Colombia, Congo (DRC), Costa Rica, Côte d'Ivoire, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Eswatini, Ethiopia, Fiji, Gambia, Georgia, Ghana, Grenada, Guatemala, Guyana, Honduras, India, Indonesia, Iran (Islamic Republic of), Iraq, Jamaica, Jordan, Kenya, Kosovo, Lao People's Democratic Republic, Lebanon, Lesotho, Liberia, Malawi, Maldives, Mali, Mauritius, Mongolia, Montenegro, Morocco, Mozambique, Nauru, Nepal, Nicaragua, Nigeria, North Macedonia, Oman, Palestine, Paraguay, Peru, Philippines, Qatar, Republic of Korea, Republic of Moldova, Rwanda, Samoa, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Sierra Leone, Solomon Islands, Somalia, South Sudan, Sri Lanka, St. Lucia*, Sudan, Suriname, Taiwan, Tajikistan, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Tuvalu, Uganda, Uruguay, Uzbekistan, Viet Nam, Yemen. *100th Facility participant to receive a COVAX delivery About COVAX COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, is co-convened by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance Gavi) and the World Health Organization (WHO) – working in partnership with UNICEF as key implementing partner, developed and developing country vaccine manufacturers, the World Bank, and others. It is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both higher-income and lower-income countries.CEPI’s role in COVAXCEPI is leading on the COVAX vaccine research and development portfolio, investing in R&D across a variety of promising candidates, with the goal to support development of three safe and effective vaccines which can be made available to countries participating in the COVAX Facility. As part of this work, CEPI has secured first right of refusal to potentially over one billion doses for the COVAX Facility to a number of candidates, and made strategic investments in vaccine manufacturing, which includes reserving capacity to manufacture doses of COVAX vaccines at a network of facilities, and securing glass vials to hold 2 billion doses of vaccine. CEPI is also investing in the ‘next generation’ of vaccine candidates, which will give the world additional options to control COVID-19 in the future.  Gavi’s role in COVAXGavi is leading on procurement and delivery at scale for COVAX: coordinating the design, implementation and administration of the COVAX Facility and the COVAX AMC and working with its Alliance partners UNICEF and WHO, along with governments, on country readiness and delivery. As part of this role, Gavi hosts the Office of the COVAX Facility to coordinate the operation and governance of the mechanism as a whole, manages relationships with Facility participants, and negotiates advance purchase agreements with manufacturers of promising vaccine candidates on behalf of the 190 economies participating in the COVAX Facility. It also coordinates design, operation and fundraising for the COVAX AMC that supports 92 lower-income economies, including a no-fault compensation mechanism that will be administered by WHO. As part of this work, Gavi supports governments and partners on ensuring country readiness, providing funding and oversight of UNICEF procurement of vaccines as well as partners’ and governments work on readiness and delivery. This includes support for cold chain equipment, technical assistance, syringes, vehicles, and other aspects of the vastly complex logistical operation for delivery.WHO’s role in COVAXWHO has multiple roles within COVAX: It provides normative guidance on vaccine policy, regulation, safety, R&D, allocation, and country readiness and delivery. Its Strategic Advisory Group of Experts (SAGE) on Immunization develops evidence-based immunization policy recommendations. Its Emergency Use Listing (EUL) / prequalification programmes ensure harmonized review and authorization across member states. It provides global coordination and member state support on vaccine safety monitoring. It developed the target product profiles for COVID-19 vaccines and provides R&D technical coordination. WHO leads, together with UNICEF, the Country Readiness and Delivery workstream, which provides support to countries as they prepare to receive and administer vaccines. Along with Gavi and numerous other partners working at the global, regional, and country-level, the CRD workstream provides tools, guidance, monitoring, and on the ground technical assistance for the planning and roll-out of the vaccines. Along with COVAX partners, WHO has developed a no-fault compensation scheme as part of the time-limited indemnification and liability commitments.UNICEF’s role in COVAXUNICEF is leveraging its experience as the largest single vaccine buyer in the world and working with manufacturers and partners on the procurement of COVID-19 vaccine doses, as well as freight, logistics and storage. UNICEF already procures more than 2 billion doses of vaccines annually for routine immunization and outbreak response on behalf of nearly 100 countries. In collaboration with the PAHO Revolving Fund, UNICEF is leading efforts to procure and supply doses of COVID-19 vaccines for COVAX. In addition, UNICEF, Gavi and WHO are working with governments around the clock to ensure that countries are ready to receive the vaccines, with appropriate cold chain equipment in place and health workers trained to dispense them. UNICEF is also playing a lead role in efforts to foster trust in vaccines, delivering vaccine confidence communications and tracking and addressing misinformation around the world.About ACT-AcceleratorThe Access to COVID-19 Tools ACT-Accelerator, is a new, ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. It was set up in response to a call from G20 leaders in March 2020 and launched by the WHO, European Commission, France and The Bill & Melinda Gates Foundation in April 2020. The ACT-Accelerator is not a decision-making body or a new organization, but works to speed up collaborative efforts among existing organizations to end the pandemic. It is a framework for collaboration that has been designed to bring key players around the table with the goal of ending the pandemic as quickly as possible through the accelerated development, equitable allocation, and scaled up delivery of tests, treatments and vaccines, thereby protecting health systems and restoring societies and economies in the near term. It draws on the experience of leading global health organizations which are tackling the world’s toughest health challenges, and who, by working together, are able to unlock new and more ambitious results against COVID-19. Its members share a commitment to ensure all people have access to all the tools needed to defeat COVID-19 and to work with unprecedented levels of partnership to achieve it.The ACT-Accelerator has four areas of work: diagnostics, therapeutics, vaccines and the health system connector. Cross-cutting all of these is the workstream on Access & Allocation.


via arabnews04/01/2021

Two more teachers suspended amid UK school's prophet cartoon row - Arab News

LONDON: Two more teachers have been suspended for their role in showing a cartoon of the Prophet Muhammad during a religious studies class in a British school, the Daily Mail reported on Thursday. Three teachers at Batley Grammar School in West Yorkshire have now been suspended pending investigation. The first unnamed teacher was suspended after parents protested outside the

via arabnews04/01/2021

British company launches hijabs for barristers - Arab News

LONDON: In a first of its kind, a British company has launched a range of hijabs designed specifically for female advocates to wear in court. British hijab-wearing barristers do not have to wear the country’s distinctive white wigs in court, but until now there had been no standard for what they should wear instead. Seeking to change this, British legal-wear designer Ivy &

via urdupoint03/31/2021

Moldova's Ex-President Dodon Says COVID-19 State of Emergency Safe for Businesses, Travel - UrduPoint News

The potential state of emergency in Moldova will not necessarily entail a new lockdown with hard restrictions on movements and business operations, Igor Dodon, a former Moldovan president and currently the leader of the Party of Socialists, said on Wednesday.On Tuesday, Acting Justice Minister Fadei ..

via finance.yahoo03/30/2021

Xebec Supports Fight Against COVID-19 as Hospitals Adopt On-site Oxygen Generation - Yahoo Finance

Continued traction for medical on-site oxygen generators as demand increases worldwideMONTREAL, March 30, 2021 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. (TSX: XBC) (“Xebec”), a global provider of clean energy solutions, is pleased to announce today that its wholly owned subsidiary Inmatec, has received an order for 14 POC medical on-site oxygen generators for hospitals in Moldova. This contract follows a number of recent orders including one placed in December 2020 for 48 units, valued at €1.7 million, for hospitals in India. In addition, Inmatec has completed a number of high-profile deliveries to healthcare facilities in Peru, United Kingdom, Africa and the Middle East. Medical oxygen has seen surging demand as a result of the worldwide COVID-19 pandemic. Oxygen is used by patients with severe symptoms of COVID-19, in addition in patients requiring oxygen for other disease states such as chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and asthma. As a result of the new demand, supply bottlenecks for the gas have been created and this has showcased the challenges with securing oxygen from centralized sources. Xebec is supporting the fight against COVID-19 with its on-site oxygen generation products, which improve the supply and delivery constraints by providing an economical means for on-site production. By adopting these products, hospitals get access to immediate, stable production at up to 60% lower cost and lower carbon emissions than traditional supply options. “We are proud to be playing our part in fighting the novel coronavirus. Oxygen shortages continue to be rampant around the world in both developed and developing countries. Most importantly, Inmatec enables remote hospitals to have economical access to oxygen for patients on ventilators, in operating theatres under anesthesia, and to fill cylinders. This same technology platform can also be applied for fish farming, wastewater treatment and renewable natural gas production. Xebec is becoming a key player in distributed gas generation with an aim to lower costs and emissions for customers,” stated Marinus van Driel, President of Xebec Europe. 2020 saw an accelerated adoption of medical on-site oxygen generationIn response to the pandemic, numerous governments implemented measures, adjusted regulations or made direct investments to secure adequate oxygen production. As a result of the improved backdrop, Inmatec delivered 224 oxygen generators in 2020, up from 118 in the previous year, resulting in revenue more than tripling. Xebec expects that customers around the world will continue to recognize the benefits of on-site oxygen generation and consequently has delivered (as of March 22, 2021) 66 units in 2021 to customers around the globe and has received orders for another 67 units. Related links:https://www.xebecinc.comhttps://www.inmatec.de/en/startsite.htmlhttps://www.inmatec.de/en/news-stories-details/oxygen-generator-provides-improved-medical-care-at-st-kizito-hospital-in-uganda.html Media Inquiries:Public Relations for XebecVictor Henriquez, Senior Partnervictor@publicsc.com+1 514.377.1102 Investor Relations:Xebec Adsorption Inc.Brandon Chow, Director, Investor Relationsbchow@xebecinc.com+1 450.979.8700 ext 5762 About Xebec Adsorption Inc.Xebec is a global provider of clean energy solutions for renewable and low carbon gases used in energy, mobility and industry applications. The company specializes in deploying a portfolio of proprietary technologies for the distributed production of hydrogen, renewable natural gas, oxygen and nitrogen. By focusing on environmentally responsible gas generation, Xebec has helped thousands of customers around the world reduce their carbon footprints and operating costs. Headquartered in Québec, Canada, Xebec has a worldwide presence with five manufacturing facilities, eight Cleantech Service Centers and four sales offices spanning over four continents. Xebec trades on the Toronto Stock Exchange under the symbol (TSX: XBC). For more information, xebecinc.com. Cautionary Statement This news release contains forward-looking statements and forward-looking information (together, “forward-looking statements”) within the meaning of applicable securities laws. All statements, other than statements of historical facts, are forward-looking statements, and subject to risks and uncertainties. Generally, forward-looking statements can be identified by the use of terminology such as “plans”, “seeks”, “expects”, “estimates”, “intends”, “anticipates”, “believes”, “could”, “might”, “likely” or variations of such words, or statements that certain actions, events or results “may”, “will”, “could”, “would”, “might”, “will be taken”, “occur”, “be achieved” or other similar expressions. Forward-looking statements, including statements concerning future capital expenditures, revenues, expenses, earnings, economic performance, indebtedness, financial condition, losses and future prospects as well as the expectations of management of Xebec with respect to information regarding the business and the expansion and growth of Xebec operations, involve risks, uncertainties and other factors that could cause actual results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements are subject to business and economic factors and uncertainties, and other factors that could cause actual results to differ materially from these forward-looking statements, including the relevant assumptions and risks factors set out in Xebec's public documents, including in the most recent annual management discussion and analysis and annual information form, filed on SEDAR at www.sedar.com. Furthermore, should one or more of the risks, uncertainties or other factors materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. These risks, uncertainties and other factors include, among others, the uncertain and unpredictable condition of global economy, notably as a consequence of the Covid-19 pandemic, Xebec’s capacity to generate revenue growth, the availability to Xebec of financing and credit alternatives and access to capital, Xebec’s capacity to meet all its other commitments and business plans, Xebec’s limited number of customers, the potential loss of key employees, changes in the use of proceeds relating to the loan, share price volatility, and other factors. Although Xebec believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed times frames or at all. Except where required by applicable law, Xebec disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

via shape.nato.int03/30/2021

Coronavirus response: NATO support to the Republic of Moldova - NATO HQ

On 29 March the Republic of Moldova received 100,000 face masks (FFP2) from NATO’s Pandemic Response Trust Fund. The donation was coordinated by NATO’s Euro-Atlantic Disaster Response Coordination Centre (EADRCC) in response to Moldova’s request for international assistance. It was made possible with financial contributions by Luxembourg and Norway. The transportation from Luxembourg to the Republic of Moldova was made possible through the in-kind offer from Romania and carried out by the Romanian Air Force. The transportation was coordinated by the Standing Joint Logistics Support Group at the Supreme Headquarters Allied Powers Europe (SHAPE).


via schengenvisainfo04/06/2021

Lithuania Imposes Stricter Entry Rules for Arrivals From Belgium & the Netherlands - SchengenVisaInfo.com - SchengenVisaInfo.com

The Lithuanian Government has added Belgium, Netherlands, Bosnia and Herzegovina, Moldova, Bermuda, and Curacao to the list of highly affected COVID-19 countries due to their increased number of reported cases. On the other hand, the Government announced that Malta will no longer be part of the same list, SchengenVisaInfo.com reports. In a press release issued […]

via finance.yahoo04/02/2021

5 reasons why you should add Moldova to your post-pandemic travel list - Yahoo Finance

We're writing with good news: over 20 Moldovan hotels, wineries and guesthouses have received a Covid-19 Safe Travel certificate from the World Travel and Tourism Council. So, if you're looking to discover a new country, all while enjoying fabulous foods and wines, here is why Moldova, the least visited country in Europe — with an 83% drop in tourism since the pandemic — should be on your list once you can travel:

via arabnews04/01/2021

Hospital workers despair as France's virus strategy flails - Arab News

AMIENS — As France battles a new virus surge that many believe was avoidable, intensive care aide Stephanie Sannier manages her distress by climbing into her car after a 12-hour shift, blasting music and singing loudly. “It allows me to breathe and to cry,” she says. People with COVID-19 occupy all the beds in her ICU ward in President Emmanuel Macron’s hometown hospital in

via arabnews04/01/2021

Two dead as violence mars election in Indian battleground state - Arab News

NANDIGRAM: Two people died as an Indian state notorious for political violence went to the polls Thursday with Prime Minister Narendra Modi battling to oust a bitter rival from power. Clashes were reported across West Bengal and election officials said that voters were being “intimidated” on the second day of polling in the key state. Modi’s Hindu-nationalist Bharatiya Janata

via arabnews03/30/2021

Philippines' Duterte calls for patience amid anger over COVID-19 pandemic response - Arab News

MANILA: Philippines President Rodrigo Duterte has appealed for “patience and understanding” amid growing criticism over his handling of the coronavirus pandemic, which has claimed the lives of 13,191 people across the country. In a televised address late Monday, the tough-talking former mayor of Davao City told Filipinos that the government was “doing its best to manage the

via emerging-europe03/30/2021

Romania, where Covid-19 restrictions are modest, but people protest anyway - Emerging Europe

There is no Covid-19 lockdown in Romania. The terraces of cafes and restaurants are full, shops are open, parks teem with parents and children. And yet as alarming numbers of people become infected with coronavirus and die, others are protesting - some violently - against some very loose restrictions.